as 07-02-2025 4:00pm EST
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.
Founded: | 2007 | Country: | United States |
Employees: | N/A | City: | DENVER |
Market Cap: | 527.9M | IPO Year: | 2021 |
Target Price: | $5.00 | AVG Volume (30 days): | 33.9K |
Analyst Decision: | Sell | Number of Analysts: | 2 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.24 | EPS Growth: | N/A |
52 Week Low/High: | $2.60 - $6.69 | Next Earning Date: | 05-06-2025 |
Revenue: | $831,683,000 | Revenue Growth: | 12.19% |
Revenue Growth (this year): | 13.77% | Revenue Growth (next year): | 10.12% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
ZORETIC RICHARD C | INNV | Director | May 28 '25 | Buy | $4.06 | 42,715 | $173,306.60 | 45,779 | |
ZORETIC RICHARD C | INNV | Director | May 21 '25 | Buy | $4.05 | 3,045 | $12,308.25 | 45,779 | |
ZORETIC RICHARD C | INNV | Director | May 16 '25 | Buy | $4.24 | 2,893 | $12,317.48 | 45,779 | |
SCARBROUGH MICHAEL ANTHONY | INNV | President and COO | May 9 '25 | Buy | $3.72 | 33,000 | $122,890.00 | 33,000 |
INNV Breaking Stock News: Dive into INNV Ticker-Specific Updates for Smart Investing
Argus Research
6 days ago
Argus Research
8 days ago
GlobeNewswire
9 days ago
Argus Research
9 days ago
Argus Research
10 days ago
Argus Research
13 days ago
Argus Research
15 days ago
Argus Research
16 days ago
The information presented on this page, "INNV InnovAge Holding Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.